Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug ...

FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

The deal will see BMS partner with BioNTech on a bispecific antibody candidate, dubbed BNT327, of which the latter company is ...

"These computational methodologies have been extensively applied across various stages of drug development, enhancing research and development efficiency and expediting the time-to-market for ...

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

The company intended to move the drug into late-stage testing, which is generally the last phase of development before a company submits the potential treatment to government regulators for approval.